HDAC6: A Neglected Player in Chronic Obstructive Pulmonary Disease?
作者信息
Ito Kazuhiro
机构信息
National Heart and Lung Institute Imperial College London, United Kingdom.
出版信息
Am J Respir Cell Mol Biol. 2021 Dec;65(6):569-570. doi: 10.1165/rcmb.2021-0269ED.
Abstract
摘要
相似文献
1
HDAC6: A Neglected Player in Chronic Obstructive Pulmonary Disease?HDAC6：慢性阻塞性肺疾病中一个被忽视的因素？
Am J Respir Cell Mol Biol. 2021 Dec;65(6):569-570. doi: 10.1165/rcmb.2021-0269ED.
2
Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction.组蛋白去乙酰化酶 6 介导的选择性自噬调节 COPD 相关纤毛功能障碍。
J Clin Invest. 2013 Dec;123(12):5212-30. doi: 10.1172/JCI69636. Epub 2013 Nov 8.
3
Analysis of Expression and Functions of Histone Deacetylase 6 (HDAC6).组蛋白去乙酰化酶6（HDAC6）的表达及功能分析
Methods Mol Biol. 2016;1436:85-94. doi: 10.1007/978-1-4939-3667-0_6.
4
Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin.组蛋白去乙酰化酶6（HDAC6）是α-微管蛋白的一种独立去乙酰化酶。
Protein Pept Lett. 2010 May;17(5):555-8. doi: 10.2174/092986610791112620.
5
Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.通过乙酰化调节组蛋白去乙酰化酶 6（HDAC6）的核输入和微管蛋白去乙酰化酶活性。
J Biol Chem. 2012 Aug 17;287(34):29168-74. doi: 10.1074/jbc.M112.371120. Epub 2012 Jul 9.
6
Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity.淋巴细胞趋化性由组蛋白去乙酰化酶6调控，与其去乙酰化酶活性无关。
Mol Biol Cell. 2006 Aug;17(8):3435-45. doi: 10.1091/mbc.e06-01-0008. Epub 2006 May 31.
7
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity.组蛋白去乙酰化酶 6 抑制剂研究进展综述：结构特异性与功能多样性
J Med Chem. 2021 Feb 11;64(3):1362-1391. doi: 10.1021/acs.jmedchem.0c01782. Epub 2021 Feb 1.
8
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.组蛋白去乙酰化酶6的抑制作用使热休克蛋白90乙酰化并破坏其伴侣功能：组蛋白去乙酰化酶抑制剂抗白血病活性的新基础。
J Biol Chem. 2005 Jul 22;280(29):26729-34. doi: 10.1074/jbc.C500186200. Epub 2005 Jun 2.
9
Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules.组蛋白去乙酰化酶 6 通过其底物乙酰化微管来下调病毒成分向质膜的运输，从而抑制甲型流感病毒的释放。
J Virol. 2014 Oct;88(19):11229-39. doi: 10.1128/JVI.00727-14. Epub 2014 Jul 16.
10
Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.组蛋白去乙酰化酶 6（HDAC6）去乙酰化酶活性的抑制增加了其与微管的结合，并抑制 MCF-7 细胞中的微管动态不稳定性。
J Biol Chem. 2013 Aug 2;288(31):22516-26. doi: 10.1074/jbc.M113.489328. Epub 2013 Jun 24.
引用本文的文献
1
HDAC6-selective inhibitor CAY10603 ameliorates cigarette smoke-induced small airway remodeling by regulating epithelial barrier dysfunction and reversing.HDAC6选择性抑制剂CAY10603通过调节上皮屏障功能障碍和逆转来改善香烟烟雾诱导的小气道重塑。
Respir Res. 2024 Feb 5;25(1):66. doi: 10.1186/s12931-024-02688-3.
本文引用的文献
1
HDAC6 Activates ERK in Airway and Pulmonary Vascular Remodeling of Chronic Obstructive Pulmonary Disease.HDAC6 在慢性阻塞性肺疾病的气道和肺血管重塑中激活 ERK。
Am J Respir Cell Mol Biol. 2021 Dec;65(6):603-614. doi: 10.1165/rcmb.2020-0520OC.
2
First-in-Class Selective HDAC6 Inhibitor (ACY-1215) Has a Highly Favorable Safety Profile in Patients with Relapsed and Refractory Lymphoma.首类选择性组蛋白去乙酰化酶 6 抑制剂（ACY-1215）在复发/难治性淋巴瘤患者中具有良好的安全性。
Oncologist. 2021 Mar;26(3):184-e366. doi: 10.1002/onco.13673. Epub 2021 Feb 9.
3
HDAC6 as privileged target in drug discovery: A perspective.组蛋白去乙酰化酶 6 作为药物发现中的优势靶点：一个视角。
Pharmacol Res. 2021 Jan;163:105274. doi: 10.1016/j.phrs.2020.105274. Epub 2020 Nov 7.
4
Targeted inhibition of histone deacetylase 6 in inflammatory diseases.靶向抑制炎症性疾病中的组蛋白去乙酰化酶 6。
Thorac Cancer. 2019 Mar;10(3):405-412. doi: 10.1111/1759-7714.12974. Epub 2019 Jan 21.
5
Histone deacetylase 6 in cancer.组蛋白去乙酰化酶 6 在癌症中的作用。
J Hematol Oncol. 2018 Sep 3;11(1):111. doi: 10.1186/s13045-018-0654-9.
6
HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension.HDAC6：一种新型组蛋白去乙酰化酶与肺动脉高压相关。
Sci Rep. 2017 Jul 3;7(1):4546. doi: 10.1038/s41598-017-04874-4.
7
Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma.利洛司他联合硼替佐米和地塞米松治疗复发/难治性多发性骨髓瘤：首个选择性组蛋白去乙酰化酶 6 抑制剂
Clin Cancer Res. 2017 Jul 1;23(13):3307-3315. doi: 10.1158/1078-0432.CCR-16-2526. Epub 2017 Jan 4.
8
Therapeutic effects of histone deacetylase inhibitors in a murine asthma model.组蛋白去乙酰化酶抑制剂在小鼠哮喘模型中的治疗作用。
Inflamm Res. 2016 Dec;65(12):995-1008. doi: 10.1007/s00011-016-0984-4. Epub 2016 Aug 26.
9
Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.组织蛋白酶S活性通过TLR2介导的p38丝裂原活化蛋白激酶和PI3K-Akt/p-组蛋白去乙酰化酶6信号通路控制小鼠损伤相关的血管修复。
Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1549-57. doi: 10.1161/ATVBAHA.115.307110. Epub 2016 Jun 30.
10
Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6.香烟烟雾通过组蛋白去乙酰化酶6破坏肺内皮屏障完整性并增加对急性肺损伤的易感性。
Am J Respir Cell Mol Biol. 2016 May;54(5):683-96. doi: 10.1165/rcmb.2015-0149OC.
Zotero 插件